Trans-apical and trans-axillary percutaneous aortic valve implantation as alternatives to the femoral route: Short- and middle-term results

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 49-55

  Taramasso, Maurizio ^a   Maisano, Francesco ^a   Cioni, Micaela ^a   Denti, Paolo ^a   Godino, Cosmo ^a   Montorfano, Matteo ^a   Colombo, Antonio ^a   Alfieri, Ottavio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Aortic stenosis; Trans apical TAVI; Trans axillary TAVI; Trans catheter aortic valve implantation

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; FOLLOW UP; HEART BLOCK; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AXILLA; EPIDEMIOLOGIC METHODS; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 79957977524     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.11.039     Document Type: Article

References (23)

1. Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005-1011.
2. Horstkotte D., Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988, 9(Suppl. E):57-64.
3. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., Flachskampf F., Hall R., Iung B., Kasprzak J., Nataf P., Tornos P., Torracca L., Wenink A. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28:230-268. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines.
4. Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Bärwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P., Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24:1231-1243.
5. Vahanian A., Alfieri O.R., Al-Attar N., Antunes M.J., Bax J., Cormier B., Cribier A., De Jaegere P., Fournial G., Kappetein A.P., Kovac J., Ludgate S., Maisano F., Moat N., Mohr F.W., Nataf P., Pierard L., Pomar J.L., Schofer J., Tornos P., Tuzcu M., van Hout B., von Segesser L.K., Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2008, 34:1-8.
6. Zajarias A., Cribier A.G. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009, 53:1829-1836.
7. Grube E., Schuler G., Buellesfeld L., Gerckens U., Linke A., Wenaweser P., Sauren B., Mohr F.W., Walther T., Zickmann B., Iversen S., Felderhoff T., Cartier R., Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69-76.
8. Piazza N., Grube E., Gerckens U., den Heijer P., Linke A., Luha O., Ramondo A., Ussia G., Wenaweser P., Windecker S., Laborde J.C., de Jaegere P., Serruys P.W. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008, 4:242-249.
9. Webb J.G., Pasupati S., Humphries K., Thompson C., Altwegg L., Moss R., Sinhal A., Carere R.G., Munt B., Ricci D., Ye J., Cheung A., Lichtenstein S.V. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007, 116:755-763.
10. Thomas M., Schymik G., Walther T., Himbert D., Lefèvre T., Treede H., Eggebrecht H., Rubino P., Michev I., Lange R., Anderson W.N., Wendler O. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010, 122:62-69.
11. Rodés-Cabau J., Webb J.G., Cheung A., Ye J., Dumont E., Feindel C.M., Osten M., Natarajan M.K., Velianou J.L., Martucci G., DeVarennes B., Chisholm R., Peterson M.D., Lichtenstein S.V., Nietlispach F., Doyle D., DeLarochellière R., Teoh K., Chu V., Dancea A., Lachapelle K., Cheema A., Latter D., Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55(11):1080-1090.
12. Bauer J.M., Kaiser M.J., Anthony P., Guigoz Y., Sieber C.C. The mini nutritional assessment - its history, today's practice, and future perspectives. Nutr Clin Pract 2008, 23:388-396.
13. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
14. Guyatt G.H., Sullivan M.J., Thompson P.J., Fallen E.L., Pugsley S.O., Taylor D.W., Berman L.B. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985, 132:919-923.
15. Rector T.S., Kubo S.H., Cohn J.N. Validity of the Minnesota Living With Heart Failure Questionnaire as a measure of therapeutic response to Enalapril or Placebo. Am J Cardiol 1993, 71:1106-1107.
16. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(6):473-483.
17. Maisano F., Michev I., Denti P., Alfieri O., Colombo A. Transfemoral transcatheter aortic valve implantation using the balloon expandable SAPIEN transcatheter heart valve device. MMCTS 2008, 10.1510/mmcts.2007.003087.
18. Kempfert J., Lehmann S., Linke A., Rastan A., Van Linden A., Blumenstein J., Schuler G., Mohr W.F., Walther T. Transapical transcatheter off-pump aortic valve implantation. MMCTS 2010, 10.1510/mmcts.2009.003939.
19. Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008.
20. Wendler O., Walther T., Nataf P., Rubino P., Schroefel H., Thielmann M., Treede H., Thomas M. Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg 2010, 38:119-127.
21. Walther T., Schuler G., Borger M.A., Kempfert J., Seeburger J., Rückert Y., Ender J., Linke A., Scholz M., Falk V., Mohr F.W. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010, 31:1398-1403.
22. Petronio A.S., De Carlo M., Bedogni F., Marzocchi A., Klugmann S., Maisano F., Ramondo A., Ussia G.P., Ettori F., Poli A., Brambilla N., Saia F., De Marco F., Colombo A. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010, 3:359-366.
23. Modine T., Obadia J.F., Choukroun E., Rioufoul G., Sudre A., Laborde J.C., Leprince P. Transcutaneous aortic valve implantation using the axillary/subclavian access: feasibility and early clinical outcomes. J Thorac Cardiovasc Surg 2010, [Epub ahead of print].